Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May;49(5):2077-9.
doi: 10.1128/JCM.02574-10. Epub 2011 Mar 9.

Nalidixic acid-resistant strains of Salmonella showing decreased susceptibility to fluoroquinolones in the midwestern region of the Republic of Ireland due to mutations in the gyrA gene

Michael P Ryan, Colm Dillon, Catherine C Adley

Nalidixic acid-resistant strains of Salmonella showing decreased susceptibility to fluoroquinolones in the midwestern region of the Republic of Ireland due to mutations in the gyrA gene

Michael P Ryan et al. J Clin Microbiol. 2011 May.
No abstract available

PubMed Disclaimer

References

    1. Aarestrup F. M., Wiuff C., Molbak K., Threlfall E. J. 2003. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob. Agents Chemother. 47:827–829 - PMC - PubMed
    1. Clinical and Laboratory Standards Institute 2008. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement; CLSI document M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA
    1. Crump J. A., Barrett T. J., Nelson J. T., Angulo F. J. 2003. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin. Infect. Dis. 37:75–81 - PubMed
    1. European Food Safety Authority 2010. Manual for reporting on zoonoses, zoonotic agents and antimicrobial resistance in the framework of Directive 2003/99/EC and of some other pathogenic microbiological agents for information derived from the reporting year 2009. EFSA J. 8:1579 http://www.efsa.europa.eu/en/scdocs/doc/1579.pdf
    1. Giraud E., Brisabois A., Martel J. L., Chaslus-Dancla E. 1999. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob. Agents Chemother. 43:2131–2137 - PMC - PubMed

Associated data